Equity InsiderA $190 Billion Weight-Loss Boom Exposed a Tissue-Restoration Gap, and One Nasdaq Company Is Moving to Fill ItEquity Insider•12 min read
Equity InsiderThe West Wants a Critical-Minerals Supply Chain Outside China. One Nasdaq Company Is Trying to Build a Piece of It in Greenland.Equity Insider•12 min read
Equity InsiderFusion Was a Punchline – General Fusion Heated Plasma to 8.4 Million Degrees by Squeezing ItEquity Insider•23 min read
Equity InsiderFrom the Lab to the Grid: General Fusion Signs a Framework to Bring Fusion Power to ItalyEquity Insider•18 min read
Equity InsiderThe Aesthetics Giants Just Confirmed “Ozempic Face” Is Real — and a Newly Public Regenerative Player Wants to Compete for ItEquity Insider•10 min read
Equity InsiderVisionWave Holdings, Inc. Announces Filing of U.S. Provisional Patent Application for SDNN™ Symbiotic Deep Neural Network Architecture for Autonomous Defense and Intelligent SystemsEquity Insider•15 min read
Equity Insider16 Million People, One Underserved Disease: The AI Imaging Push to Close the Congenital Heart GapEquity Insider•13 min read
Equity InsiderThe Quiet Bottleneck in AI Drug Discovery Isn't the Model — It's the Biology Underneath ItEquity Insider•13 min read
Equity InsiderA Wartime Tungsten Mine the U.S. Government Wanted Drilled — but Never Did — Just Changed HandsEquity Insider•14 min read
Equity InsiderThe Frontier Goes Public — and the Whole Sector Comes With ItEquity Insider•11 min read
Equity InsiderAfter CAR-T, the Next Frontier in Cancer Immunotherapy May Belong to a Different Immune CellEquity Insider•11 min read
Equity InsiderSign Up Now, Never Pay: Eagle Eye Market Intelligence Takes It Up a Notch – Free for LifeMarkets & Headlines•3 min read
Equity InsiderA Fresh FDA Catalyst Is Putting Regenerative Wound Care in Focus Issued on behalf of Conexeu Sciences Inc.Equity Insider•13 min read
Equity InsiderThis Gold Story Is Starting to Look Bigger Than a Few High-Grade SamplesEquity Insider•11 min read
